Hypoxia-guided chemoradiotherapy is feasible for patients with HPV-related oropharyngeal cancer, according to researchers.
News
Localized cancer incidence decreased the most among men, Hispanic patients, individuals with larynx cancer.
Patients with HPV-related oropharyngeal cancer have lower overall survival rates if they are treated at community cancer centers rather than academic centers, data suggest.
Coherus has launched the Loqtorzi Solutions program, which provides support services to prescribers and patients.
Adding toripalimab to first-line chemotherapy improved survival in patients with recurrent or metastatic nasopharyngeal carcinoma.
Minimal axial diameter ≥6 mm independently predicted progression-free survival in all patients, those with N0 to N1 disease.
Certain aspects of oral health associated with overall survival in a study of patients with head and neck squamous cell carcinoma.
Using next-generation sequencing to guide treatment is feasible in patients with platinum-refractory head and neck cancer, according to researchers.
Annual follow-up with 18FDG-PET/CT may improve survival, as compared to conventional follow-up, in patients with head and neck cancer.
Patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy are less likely to experience emesis when given fosaprepitant weekly rather than every 3 weeks, a study suggests.